{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:20:09Z","timestamp":1794057609078,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in women worldwide. Recently, studies have been published with inconsistent findings regarding whether sarcopenia is a risk factor for mortality in breast cancer patients. Therefore, the aim of this systematic review and meta-analysis was to systematically assess and quantify sarcopenia as a risk factor for mortality in breast cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a systematic literature review of PubMed, EMBASE, and the Cochrane CENTRAL Library, we searched for observational studies written in English (from database inception until April 30, 2019) that reported an association between sarcopenia and breast cancer in women who were 18\u2009years or older.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of six studies (5497 participants) were included in this meta-analysis. Breast cancer patients with sarcopenia were associated with a significantly higher risk of mortality, compared to breast cancer patients without sarcopenia (pooled HR-hazard ratio\u2009=\u20091.71, 95% CI: 1.25\u20132.33, I<jats:sup>2<\/jats:sup>\u2009=\u200959.1%). In addition, the results of age subgroup analysis showed that participants younger than 55\u2009years with sarcopenia had a lower risk of mortality than participants aged 55\u2009years and older with sarcopenia (pooled HR\u2009=\u20091.46, 95% CI: 1.24\u20131.72 versus pooled HR\u2009=\u20091.99, 95% CI: 1.05\u20133.78), whereas both have an increased risk of mortality compared to non-sarcopenic patients. Subgroup analyses regarding stage at diagnosis revealed an increased risk of mortality in non-metastatic patients compared to participants without sarcopenia (pooled HR\u2009=\u20091.91, 95% CI: 1.32\u20132.78), whereas the association was not significant in metastatic breast cancer patients. Other subgroup analyses were performed using different follow-up periods (&gt;\u20095\u2009years versus \u22645\u2009years) and the results were different (pooled HR\u2009=\u20091.81, 95% CI: 1.23\u20132.65 versus pooled HR\u2009=\u20091.70, 95% CI: 0.80\u20133.62).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study found that sarcopenia is a risk factor for mortality among female early breast cancer patients. It is imperative that more research into specific interventions aimed at treating sarcopenia be conducted in the near future in order to provide evidence which could lead to decreased mortality rates in breast cancer patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-6645-6","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T15:02:39Z","timestamp":1583334159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiao-Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Li","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy S. K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"issue":"2","key":"6645_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"6645_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"6645_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1158\/1055-9965.EPI-18-0976","volume":"28","author":"LL Visser","year":"2019","unstructured":"Visser LL, Groen EJ, van Leeuwen FE, Lips EH, Schmidt MK, Wesseling J. Predictors of an invasive breast Cancer recurrence after DCIS: a systematic review and meta-analyses. Cancer Epidemiol Biomarkers Prev. 2019;28(5):835\u201345.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"6645_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"6645_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"issue":"2","key":"6645_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jcsm.12391","volume":"10","author":"IMG da Rocha","year":"2019","unstructured":"da Rocha IMG, Marcadenti A, de Medeiros GOC, Bezerra RA, Rego JFM, Gonzalez MC, Fayh APT. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study. J Cachexia Sarcopenia Muscle. 2019;10(2):445\u201354.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"6645_CR7","doi-asserted-by":"publisher","unstructured":"Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO, Lim SB, Kim CW, Yoon YS, Lee JL, et al. Association of Body Composition with long-term survival in non-metastatic rectal Cancer patients. Cancer Res Treat. 2019. https:\/\/doi.org\/10.4143\/crt.2019.249.","DOI":"10.4143\/crt.2019.249"},{"issue":"4","key":"6645_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"Alfonso J Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. https:\/\/doi.org\/10.1093\/ageing\/afz046.","journal-title":"Age and Ageing"},{"issue":"10191","key":"6645_CR9","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636\u201346.","journal-title":"Lancet"},{"issue":"4","key":"6645_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.clnu.2017.07.010","volume":"37","author":"F Pamoukdjian","year":"2018","unstructured":"Pamoukdjian F, Bouillet T, Levy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review. Clin Nutr. 2018;37(4):1101\u201313.","journal-title":"Clin Nutr"},{"issue":"5","key":"6645_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jviscsurg.2015.08.001","volume":"152","author":"M Cornet","year":"2015","unstructured":"Cornet M, Lim C, Salloum C, Lazzati A, Compagnon P, Pascal G, Azoulay D. Prognostic value of sarcopenia in liver surgery. J Visc Surg. 2015;152(5):297\u2013304.","journal-title":"J Visc Surg"},{"issue":"8","key":"6645_CR12","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin cancer Res. 2009;15(8):2920\u20136.","journal-title":"Clin cancer Res"},{"key":"6645_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.radonc.2019.04.023","volume":"137","author":"RG Ganju","year":"2019","unstructured":"Ganju RG, Morse R, Hoover A, TenNapel M, Lominska CE. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation. Radiother Oncol. 2019;137:117\u201324.","journal-title":"Radiother Oncol"},{"key":"6645_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58\u201367.","journal-title":"Eur J Cancer"},{"issue":"6","key":"6645_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan BJ, Cespedes Feliciano EM, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, Quesenberry CP, Weltzien EK, Castillo AL, Olobatuyi TA, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):798\u2013804.","journal-title":"JAMA Oncol"},{"issue":"3","key":"6645_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","volume":"23","author":"SS Shachar","year":"2017","unstructured":"Shachar SS, Deal AM, Weinberg M, Nyrop KA, Williams GR, Nishijima TF, Benbow JM, Muss HB. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res. 2017;23(3):658\u201365.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6645_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00520-017-3902-6","volume":"26","author":"E Deluche","year":"2018","unstructured":"Deluche E, Leobon S, Desport JC, Venat-Bouvet L, Usseglio J, Tubiana-Mathieu N. Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer. 2018;26(3):861\u20138.","journal-title":"Support Care Cancer"},{"key":"6645_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.breast.2016.10.014","volume":"31","author":"HN Rier","year":"2017","unstructured":"Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock M, Levin MD. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast. 2017;31:9\u201315.","journal-title":"Breast"},{"issue":"4","key":"6645_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11764-012-0234-x","volume":"6","author":"A Villase\u00f1or","year":"2012","unstructured":"Villase\u00f1or A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL study. J Cancer Surviv. 2012;6(4):398\u2013406.","journal-title":"J Cancer Surviv"},{"issue":"2","key":"6645_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10549-018-4915-7","volume":"172","author":"EJ Song","year":"2018","unstructured":"Song EJ, Lee CW, Jung SY, Kim BN, Lee KS, Lee S, Kang HS, Park IH, Lee MH, Kim YJ, et al. Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer. Breast Cancer Res Treat. 2018;172(2):425\u201336.","journal-title":"Breast Cancer Res Treat"},{"key":"6645_CR21","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.ctarc.2019.100154","volume":"21","author":"F Rossi","year":"2019","unstructured":"Rossi F, Valdora F, Bignotti B, Torri L, Succio G, Tagliafico AS. Evaluation of body computed tomography-determined sarcopenia in breast cancer patients and clinical outcomes: a systematic review. Cancer Treat Res Commun. 2019;21:100154.","journal-title":"Cancer Treat Res Commun"},{"issue":"7414","key":"6645_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"6645_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.maturitas.2017.04.007","volume":"103","author":"P Liu","year":"2017","unstructured":"Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16\u201322.","journal-title":"Maturitas"},{"issue":"11","key":"6645_CR24","doi-asserted-by":"publisher","first-page":"e021252","DOI":"10.1136\/bmjopen-2017-021252","volume":"8","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang C, Dou Q, Zhang W, Yang Y, Xie X. Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. BMJ Open. 2018;8(11):e021252.","journal-title":"BMJ Open"},{"issue":"5","key":"6645_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ejso.2018.09.026","volume":"45","author":"HY Deng","year":"2019","unstructured":"Deng HY, Hou L, Zha P, Huang KL, Peng L. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: a comprehensive systematic review and meta-analysis. Eur J Surg Oncol. 2019;45(5):728\u201335.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"6645_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10120-018-0882-2","volume":"22","author":"SK Kamarajah","year":"2019","unstructured":"Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019;22(1):10\u201322.","journal-title":"Gastric Cancer"},{"issue":"10","key":"6645_CR27","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00384-018-3128-1","volume":"33","author":"G Sun","year":"2018","unstructured":"Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X, Zhang Q, Li Z. Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Color Dis. 2018;33(10):1419\u201327.","journal-title":"Int J Color Dis"},{"issue":"3","key":"6645_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-016-3900-2","volume":"158","author":"SC Adams","year":"2016","unstructured":"Adams SC, Segal RJ, McKenzie DC, Vallerand JR, Morielli AR, Mackey JR, Gelmon K, Friedenreich CM, Reid RD, Courneya KS. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. Breast Cancer Res Treat. 2016;158(3):497\u2013507.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"6645_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1200\/JCO.2017.75.7526","volume":"36","author":"CM Dieli-Conwright","year":"2018","unstructured":"Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Buchanan TA, Spicer DV, Tripathy D, Bernstein L, Mortimer JE. Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese survivors of breast cancer: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36(9):875\u201383.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"6645_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1517\/13543781003724690","volume":"19","author":"T Kung","year":"2010","unstructured":"Kung T, Springer J, Doehner W, Anker SD, von Haehling S. Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia conference. Expert Opin Investig Drugs. 2010;19(4):579\u201385.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"6645_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MCO.0000000000000032","volume":"17","author":"FG Di Girolamo","year":"2014","unstructured":"Di Girolamo FG, Situlin R, Mazzucco S, Valentini R, Toigo G, Biolo G. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014;17(2):145\u201350.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"6645_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ageing\/afy106","volume":"48","author":"AJ Mayhew","year":"2019","unstructured":"Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, Thabane L, Raina P. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48(1):48\u201356.","journal-title":"Age Ageing"},{"issue":"1","key":"6645_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clnu.2019.01.002","volume":"39","author":"X Zhang","year":"2019","unstructured":"Zhang X, Huang P, Dou Q, Wang C, Zhang W, Yang Y, Wang J, Xie X, Zhou J, Zeng Y. Falls among older adults with sarcopenia dwelling in nursing home or community: a meta-analysis. Clin Nutr. 2019;39(1):33\u20139.","journal-title":"Clin Nutr"},{"issue":"1","key":"6645_CR34","doi-asserted-by":"publisher","first-page":"e0169548","DOI":"10.1371\/journal.pone.0169548","volume":"12","author":"C Beaudart","year":"2017","unstructured":"Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548.","journal-title":"PLoS One"},{"issue":"11","key":"6645_CR35","first-page":"1339","volume":"81","author":"KL Maughan","year":"2010","unstructured":"Maughan KL, Lutterbie MA, Ham PS. Treatment of breast cancer. Am Fam Physician. 2010;81(11):1339\u201346.","journal-title":"Am Fam Physician"},{"issue":"5","key":"6645_CR36","first-page":"303","volume":"5","author":"D Du Bois","year":"1989","unstructured":"Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutr. 1989;5(5):303\u201311 discussion 312-313.","journal-title":"Nutr"},{"key":"6645_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","volume":"22","author":"JM Argiles","year":"2015","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100\u20136.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"6645_CR38","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/s41598-019-38893-0","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Hai S, Liu Y, Liu Y, Dong B. Skeletal muscle mass as a mortality predictor among nonagenarians and centenarians: a prospective cohort study. Sci Rep. 2019;9(1):2420.","journal-title":"Sci Rep"},{"issue":"2","key":"6645_CR39","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/cc13189","volume":"18","author":"PJ Weijs","year":"2014","unstructured":"Weijs PJ, Looijaard WG, Dekker IM, Stapel SN, Girbes AR, Oudemans-van Straaten HM, Beishuizen A. Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Crit Care. 2014;18(2):R12.","journal-title":"Crit Care"},{"issue":"12","key":"6645_CR40","doi-asserted-by":"publisher","first-page":"e172319","DOI":"10.1001\/jamaoncol.2017.2319","volume":"3","author":"EMC Feliciano","year":"2017","unstructured":"Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol. 2017;3(12):e172319.","journal-title":"JAMA Oncol"},{"issue":"1","key":"6645_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","volume":"22","author":"AL Bian","year":"2017","unstructured":"Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-alpha. Eur J Med Res. 2017;22(1):25.","journal-title":"Eur J Med Res"},{"issue":"6","key":"6645_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/1389201017666160301102713","volume":"17","author":"D Liu","year":"2016","unstructured":"Liu D, Wang X, Chen Z. Tumor necrosis factor-alpha, a regulator and therapeutic agent on breast cancer. Curr Pharm Biotechnol. 2016;17(6):486\u201394.","journal-title":"Curr Pharm Biotechnol"},{"key":"6645_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bmb\/ldq008","volume":"95","author":"MV Narici","year":"2010","unstructured":"Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull. 2010;95:139\u201359.","journal-title":"Br Med Bull"},{"issue":"11","key":"6645_CR44","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/gerona\/glw343","volume":"72","author":"L Bianchi","year":"2017","unstructured":"Bianchi L, Abete P, Bellelli G, Bo M, Cherubini A, Corica F, Di Bari M, Maggio M, Manca GM, Rizzo MR, et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci. 2017;72(11):1575\u201381.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"40","key":"6645_CR45","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.2174\/0929867324666170801095850","volume":"25","author":"TB Waltz","year":"2018","unstructured":"Waltz TB, Fivenson EM, Morevati M, Li C, Becker KG, Bohr VA, Fang EF. Sarcopenia, aging and prospective interventional strategies. Curr Med Chem. 2018;25(40):5588\u201396.","journal-title":"Curr Med Chem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6645-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:12:18Z","timestamp":1614816738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6645"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6645-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"27 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}